Laddar...
Targeting epigenetics as atherosclerosis treatment: an updated view
This review discusses the current developments on epigenetic inhibition as treatment for atherosclerosis. RECENT FINDINGS: The first phase III clinical trial targeting epigenetics in cardiovascular disease (CVD), BETonMACE, using the bromodomain inhibitor apabetalone (RVX-208) showed no significant...
Sparad:
| I publikationen: | Curr Opin Lipidol |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Lippincott Williams & Wilkins
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7752220/ https://ncbi.nlm.nih.gov/pubmed/33027226 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOL.0000000000000711 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|